CD40 ligand induces RIP1-dependent, necroptosis-like cell death in low-grade serous but not serous borderline ovarian tumor cells

Necroptosis: Pathway diversity and characteristics

(2015) M. Cristina de Almagro et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis

(2014) Conor J. Kearney et al.   FEBS Journal

Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials

(2014) Sufia Butt Hassan et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

New roles for old enzymes: killer caspases as the engine of cell behavior changes

(2014) Patrick F. Connolly et al.   Frontiers in Physiology

CD40 immunotherapy for pancreatic cancer

(2013) Robert H. Vonderheide et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research

(2013) Michael S. Anglesio et al.   PLoS One

Expression of CD40 and growth-inhibitory activity of CD40 agonist in ovarian carcinoma cells

(2012) Yan Zhou et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase

(2012) Liming Sun et al.   CELL

Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase

(2012) A Degterev et al.   CELL DEATH AND DIFFERENTIATION

T-cell-independent Antitumor Effects of CD40 Ligation

(2012) Alexander L. Rakhmilevich et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex

(2012) B A Abhari et al.   ONCOGENE

EGF-Induced EMT and Invasiveness in Serous Borderline Ovarian Tumor Cells: A Possible Step in the Transition to Low-Grade Serous Carcinoma Cells?

(2012) Jung-Chien Cheng et al.   PLoS One

TGF-Beta Induces Serous Borderline Ovarian Tumor Cell Invasion by Activating EMT but Triggers Apoptosis in Low-Grade Serous Ovarian Carcinoma Cells

(2012) Jung-Chien Cheng et al.   PLoS One

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models

(2012) N Takahashi et al.   Cell Death & Disease

Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

(2011) L Galluzzi et al.   CELL DEATH AND DIFFERENTIATION

The death domain kinase RIP1 links the immunoregulatory CD40 receptor to apoptotic signaling in carcinomas

(2011) Pauline G. Knox et al.   JOURNAL OF CELL BIOLOGY

Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells

(2011) J-C Cheng et al.   ONCOGENE

CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

(2011) G. L. Beatty et al.   SCIENCE

Distinct DNA methylation profiles in ovarian serous neoplasms and their implications in ovarian carcinogenesis

(2010) Ie-Ming Shih et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Molecular mechanisms of necroptosis: an ordered cellular explosion

(2010) Peter Vandenabeele et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin

(2010) J-C Cheng et al.   ONCOGENE

Biology and Clinical Applications of CD40 in Cancer Treatment

(2010) Ester Fonsatti et al.   SEMINARS IN ONCOLOGY

Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation

(2009) YoungSik Cho et al.   CELL

Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α

(2009) Sudan He et al.   CELL

Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells

(2009) E. M. Gomes et al.   CLINICAL CANCER RESEARCH

The Jekyll and Hyde Functions of Caspases

(2009) Caroline H. Yi et al.   DEVELOPMENTAL CELL

Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant

(2009) David M. Gershenson et al.   GYNECOLOGIC ONCOLOGY

RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis

(2009) D.-W. Zhang et al.   SCIENCE

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

(2008) G Kroemer et al.   CELL DEATH AND DIFFERENTIATION

Hematopoietic Stem Cell Responsiveness to Exogenous Signals Is Limited by Caspase-3

(2008) Viktor Janzen et al.   Cell Stem Cell

Caspase Activity Mediates the Differentiation of Embryonic Stem Cells

(2008) Jun Fujita et al.   Cell Stem Cell

SV40 early genes induce neoplastic properties in serous borderline ovarian tumor cells

(2008) Michelle M. Woo et al.   GYNECOLOGIC ONCOLOGY

Serous borderline ovarian tumors in long-term culture: phenotypic and genotypic distinction from invasive ovarian carcinomas

(2008) M.M.M. WOO et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Early Events in the Pathogenesis of Epithelial Ovarian Cancer

(2008) Charles N. Landen et al.   JOURNAL OF CLINICAL ONCOLOGY

Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis

(2008) Cornelia Hömig-Hölzel et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Caspase-independent cell death: leaving the set without the final cut

(2008) S W G Tait et al.   ONCOGENE